Application Note

Breaking The Mold: How R Is Revolutionizing CSR Generation

Business meeting remote audit GettyImages-1325899588

The CDISC Standard Data Tabulation Model (SDTM) is essential for the FDA-required Analysis Data Model (ADaM) and Tables, Figures, Listings (TFLs) in clinical trial submissions. Traditionally, the pharmaceutical industry has used SAS, a statistical analysis software, for Clinical Study Report (CSR) submissions. This leads to increased costs and process bottlenecks. However, the open-source statistical programming language R is becoming more popular in the life sciences sector due to its cost-effectiveness, inclusivity, and collaboration. In 2015, the FDA stated that it doesn't mandate the use of any specific software for statistical analyses, leading to the creation of R packages to assist with compliance and clinical research. Pharmaceutical companies such as Novo Nordisk and the R Consortium have successfully submitted ADaM datasets and TFLs using R, demonstrating its enhanced visualizations, increased usability, and wider application.

access the Application Note!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader